The DOI matches its OpenAlex record; 62 of the 62 references it cites were found in a registry or an index.
Biphasic Regulation of Breast Cancer Cell Growth by Progesterone: Role of the Cyclin-Dependent Kinase Inhibitors, p21 and p27Kip1
Open accessAbstract
Depending on the tissue, progesterone is classified as a proliferative or a differentiative hormone. To explain this paradox, and to simplify analysis of its effects, we used a breast cancer cell line (T47D-YB) that constitutively expresses the B isoform of progesterone receptors. These cells are resistant to the proliferative effects of epidermal growth factor (EGF). Progesterone treatment accelerates T47D-YB cells through the first mitotic cell cycle, but arrests them in late G1 of the second cycle. This arrest is accompanied by decreased levels of cyclins D1, D3, and E, disappearance of cyclins A and B, and sequential induction of the cyclin-dependent kinase (cdk) inhibitors p21 and p27(Kip1). The retinoblastoma protein is hypophosphorylated and extensively down-regulated. The activity of the cell cycle-dependent protein kinase, cdk2, is regulated biphasically by progesterone: it increases initially, then decreases. This is consistent with the biphasic proliferative increase followed by arrest produced by one pulse of progesterone. A second treatment with progesterone cannot restart proliferation despite adequate levels of transcriptionally competent PR. Instead, a second progesterone dose delays the fall of p21 and enhances the rise of p27(Kip1), thereby intensifying the progesterone resistance in an autoinhibitory loop. However, during the progesterone-induced arrest, the cell cycling machinery is poised to restart. The first dose of progesterone increases the levels of EGF receptors and transiently sensitizes the cells to the proliferative effects of EGF. We conclude that progesterone is neither inherently proliferative nor antiproliferative, but that it is capable of stimulating or inhibiting cell growth depending on whether treatment is transient or continuous. We also suggest that the G1 arrest after progesterone treatment is accompanied by cellular changes that permit other, possibly tissue-specific, factors to influence the final proliferative or differentiative state.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Marshall, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90401-8 · Cited by 3,906
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
Inhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243
G1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674
G 1 Events and Regulation of Cell Proliferation
Pardee, A. B. (1989) · Science · doi:10.1126/science.2683075 · Cited by 2,182
Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
Hunter, T., & Pines, J. (1994) · Cell · doi:10.1016/0092-8674(94)90543-6 · Cited by 2,091
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
Lydon, J. P., DeMayo, F. J., Funk, C. R., Mani, S. K., Hughes, A. R., Montgomery, C. A., Shyamala, G., Conneely, O. M., & O'Malley, B. W. (1995) · Genes & Development · doi:10.1101/gad.9.18.2266 · Cited by 1,862
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.
Krishan, A. (1975) · The Journal of cell biology · doi:10.1083/jcb.66.1.188 · Cited by 1,728
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
New functional activities for the p21 family of CDK inhibitors.
LaBaer, J., Garrett, M. D., Stevenson, L. F., Slingerland, J. M., Sandhu, C., Chou, H. S., Fattaey, A., & Harlow, E. (1997) · Genes & Development · doi:10.1101/gad.11.7.847 · Cited by 1,402
Signal transduction via the MAP kinases: proceed at your own RSK.
Blenis, J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.5889 · Cited by 1,243
Correlation of Terminal Cell Cycle Arrest of Skeletal Muscle with Induction of p21 by MyoD
Halevy, O., Novitch, B. G., Spicer, D. B., Skapek, S. X., Rhee, J., Hannon, G. J., Beach, D., & Lassar, A. B. (1995) · Science · doi:10.1126/science.7863327 · Cited by 1,149
D-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
p53-Independent Expression of p21 Cip1 in Muscle and Other Terminally Differentiating Cells
Parker, S. B., Eichele, G., Zhang, P., Rawls, A., Sands, A. T., Bradley, A., Olson, E. N., Harper, J. W., & Elledge, S. J. (1995) · Science · doi:10.1126/science.7863329 · Cited by 1,032
Cyclin D1 provides a link between development and oncogenesis in the retina and breast
Sicinski, P., Donaher, J. L., Parker, S. B., Li, T., Fazeli, A., Gardner, H., Haslam, S. Z., Bronson, R. T., Elledge, S. J., & Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90034-9 · Cited by 1,021
Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice
Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A., & Schmidt, E. V. (1994) · Nature · doi:10.1038/369669a0 · Cited by 965
Horwitz, K. B., & McGuire, W. L. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38062-6 · Cited by 799
Self-citationKing, R. W., Jackson, P. K., & Kirschner, M. W. (1994) · Cell · doi:10.1016/0092-8674(94)90542-8 · Cited by 738
Kato, J.-Y., Matsuoka, M., Polyak, K., Massague, J., & Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90257-7 · Cited by 720
Progestin regulation of cellular proliferation.
CLARKE, C. L., & SUTHERLAND, R. L. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-2-266 · Cited by 650
p21-containing cyclin kinases exist in both active and inactive states.
Zhang, H., Hannon, G. J., & Beach, D. (1994) · Genes & Development · doi:10.1101/gad.8.15.1750 · Cited by 632
Ordering S phase and M phase in the cell cycle
Nurse, P. (1994) · Cell · doi:10.1016/0092-8674(94)90539-8 · Cited by 589
Predicting Response to Endocrine Therapy in Human Breast Cancer: A Hypothesis
Horowitz, K. B., McGuire, W. L., Pearson, O. H., & Segaloff, A. (1975) · Science · doi:10.1126/science.168640 · Cited by 569
Induction of p21 (WAF-1/CIP1) during differentiation.
Steinman, R. A., Hoffman‐Liebermann, B., Iro, A., Guillouf, C., Liebermann, D. A., & El-Houseini, M. E. (1994) · PubMed · Cited by 477
Inhibition of Myogenic Differentiation in Proliferating Myoblasts by Cyclin D1-Dependent Kinase
Skapek, S. X., Rhee, J., Spicer, D. B., & Lassar, A. B. (1995) · Science · doi:10.1126/science.7863328 · Cited by 477
EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor
Traverse, S., Seedorf, K., Paterson, H., Marshall, C. J., Cohen, P., & Ullrich, A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00154-8 · Cited by 454
Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle
Peter, M. (1994) · Cell · doi:10.1016/0092-8674(94)90186-4 · Cited by 445
The N-terminal region of the chicken progesterone receptor specifies target gene activation
Tora, L., Gronemeyer, H., Turcotte, B., Gaub, M.-P., & Chambon, P. (1988) · Nature · doi:10.1038/333185a0 · Cited by 421
Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase
(1995) · Trends in Genetics · doi:10.1016/0168-9525(95)90555-3 · Cited by 406
Growth Factors in Breast Cancer
DICKSON, R. B., & LIPPMAN, M. E. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-5-559 · Cited by 388
Musgrove, E. A., Lee, C. S., Buckley, M. F., & Sutherland, R. L. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.17.8022 · Cited by 376
Progesterone Receptors as a Prognostic Factor in Stage II Breast Cancer
Clark, G. M., McGuire, W. L., Hubay, C. A., Pearson, O. H., & Marshall, J. S. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312013092240 · Cited by 366
Sartorius, C. A. (1994) · Molecular Endocrinology · doi:10.1210/me.8.10.1347 · Cited by 342
Stanford, J. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530020055032 · Cited by 339
The effect of age and menstrual cycle upon proliferative activity of the normal human breast
Potten, C., Watson, R., Williams, G., Tickle, S., Roberts, S., Harris, M., & Howell, A. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.185 · Cited by 311
Musgrove, E. A., Hamilton, J. A., Lee, C. S., Sweeney, K. J., Watts, C. K., & Sutherland, R. L. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3577 · Cited by 297
Heichman, K. A., & Roberts, J. M. (1994) · Cell · doi:10.1016/0092-8674(94)90541-x · Cited by 251
Horwitz, K. B., Mockus, M. B., & Lessey, B. A. (1982) · Cell · doi:10.1016/0092-8674(82)90218-5 · Cited by 246
Self-citationHORWITZ, K. B., & ALEXANDER, P. S. (1983) · Endocrinology · doi:10.1210/endo-113-6-2195 · Cited by 232
Self-citationHORWITZ, K. B. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-146 · Cited by 221
Self-citationSartorius, C. A., Groshong, S. D., Miller, L. A., Powell, R. L., Tung, L. W., Takimoto, G. S., & Horwitz, K. B. (1994) · PubMed · Cited by 212
Self-citationPC12 cells overexpressing the insulin receptor undergo insulin-dependent neuronal differentiation
Dikic, I., Schlessinger, J., & Lax, I. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00155-x · Cited by 210
Proliferative and secretory activity in human breast during natural and artificial menstrual cycles.
Going, J. J., Anderson, T. J., Battersby, S., & Macintyre, C. C. A. (1988) · Europe PMC (PubMed Central) · Cited by 208
Oral contraceptive use influences resting breast proliferation
Anderson, T. J., Battersby, S., King, R. J. B., McPherson, K., & Going, J. J. (1989) · Human Pathology · doi:10.1016/s0046-8177(89)80003-6 · Cited by 199
Regulation of p21WAF1/CIP1 expression through mitogen-activated protein kinase signaling pathway.
Liu, Y., Martindale, J. L., Gorospe, M., & Holbrook, N. J. (1996) · PubMed · Cited by 192
Musgrove, E. A., Lee, C. S., & Sutherland, R. L. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.10.5032 · Cited by 175
Characterization of progesterone receptor A and B expression in human breast cancer.
Graham, J. D., Yeates, C., Balleine, R. L., Harvey, S. S., Milliken, J. S., Bilous, A. M., & Clarke, C. L. (1995) · PubMed · Cited by 170
Meyer, M. E., Quirin-Stricker, C., Lerouge, T., Bocquel, M. T., & Gronemeyer, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50100-4 · Cited by 169
Fox, S. B., Smith, K., Hollyer, J., Greenall, M., Hastrich, D., & Harris, A. L. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666180 · Cited by 161
Estes, P. A., Suba, E. J., Lawler-Heavner, J., El‐Ashry, D., Wei, L. L., Toft, D. O., Sullivan, W. P., Horwitz, K. B., & Edwards, D. P. (1987) · Biochemistry · doi:10.1021/bi00393a045 · Cited by 157
Self-citationBinding of Zinc Finger Protein ZPR1 to the Epidermal Growth Factor Receptor
Galcheva-Gargova, Z., Konstantinov, K. N., Wu, I., Klier, F. G., Barrett, T., & Davis, R. J. (1996) · Science · doi:10.1126/science.272.5269.1797 · Cited by 129
EGF receptor expression, regulation, and function in breast cancer
Chrysogelos, S. A., & Dickson, R. B. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666179 · Cited by 105
Quian, X.-L., Decker, S. J., & Greene, M. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.4.1330 · Cited by 76
The ontogeny of gene expression of progestin receptors in the female rat brain
Kato, J., Hirata, S., Nozawa, A., & Mouri, N. (1993) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(93)90072-5 · Cited by 68
Yamauchi, K., & Pessin, J. E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.7.4427-4434.1994 · Cited by 50
Evaluating the benefits and risks of postmenopausal hormone therapy
Cummings, S. R. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90241-o · Cited by 37
Horwitz, K. B., Pike, A. W., Gonzalez-Aller, C., & Fennessey, P. V. (1986) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(86)90323-7 · Cited by 29
Self-citation
Cited by
Progesterone receptors: form and function in brain
Brinton, R. D., Thompson, R. F., Foy, M. R., Baudry, M., Wang, J., Finch, C. E., Morgan, T. E., Pike, C. J., Mack, W. J., Stanczyk, F. Z., et al. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.02.001 · Cited by 675
Differential Gene Regulation by the Two Progesterone Receptor Isoforms in Human Breast Cancer Cells
Richer, J. K., Jacobsen, B. M., Manning, N. G., Abel, M. G., Horwitz, K. B., & Wolf, D. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110090200 · Cited by 572
Self-citationProgesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer
Kim, J. J., Kurita, T., & Bulun, S. E. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1043 · Cited by 520
Fournier, A., Berrino, F., Riboli, E., Avenel, V., & Clavel‐Chapelon, F. (2005) · International Journal of Cancer · doi:10.1002/ijc.20710 · Cited by 403
Owen, G. I., Richer, J. K., Tung, L., Takimoto, G., & Horwitz, K. B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10696 · Cited by 349
Self-citation
Metadata
- Authors
- Groshong, S. D., Owen, G. I., Grimison, B., Schauer, I. E., Todd, M. C., Langan, T. A., Sclafani, R. A., Lange, C. A., & Horwitz, K. B.
- Venue
- Molecular Endocrinology
- Publisher
- Oxford University Press
- Published
- 1997-10-01
- Volume
- 11
- Issue
- 11
- Pages
- 1593-1607
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2119801679
- Cited by
- 299
- References
- 62
- FWCI
- 5.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.